Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOHN A POREMBA

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1104829506
CMS profile
708422
Location
NASHUA, NH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$127.32

2 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $127.32 2

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Dexcom, Inc. $96.31 1
Novo Nordisk Inc $31.01 1

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOHN A POREMBA

NPI 1104829506 · CMS profile ID 708422

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

NASHUA, NH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1104829506?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOHN A POREMBA, NPI 1104829506, CMS profile ID 708422. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104829506?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JOHN A POREMBA, NPI 1104829506, CMS profile ID 708422. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104829506?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JOHN A POREMBA, NPI 1104829506, CMS profile ID 708422, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1104829506?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

2 matching records · $127.32 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 2 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–2 of 2.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Dexcom, Inc. $96.3111/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153310037 CMS
Novo Nordisk Inc $31.0106/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097779621 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $149.97 1
PY2023 $215.38 2
PY2024 $127.32 2

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $95,561.30 17
PY2024 Recipient $1,872.56 14
PY2024 Principal investigator $132,599.99 97
PY2023 Recipient $388.10 1
PY2023 Principal investigator $74,957.23 177

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

111 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $4,072.00 12/31/2024 Non-covered Recipient Entity
FOUNDATION MED PARTNERS
M21-341 ATH Ph 2b Armour Thyroid vs Synthetic T4 (ATH-MD-01) (3014-301-002) No dispute reported 06/30/2026 1100764323
Principal investigator 1 ABBVIE INC. $5,103.00 12/30/2024 Non-covered Recipient Entity
FOUNDATION MEDICAL PARTNERS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1100763296
Principal investigator 1 ABBVIE INC. $5,215.05 12/05/2024 Non-covered Recipient Entity
FOUNDATION MEDICAL PARTNERS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1100759439
Principal investigator 1 Novo Nordisk AS $3,300.00 12/02/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254289
Principal investigator 1 Novo Nordisk AS $1,318.68 11/20/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254291
Principal investigator 1 ABBVIE INC. $4,207.95 11/07/2024 Non-covered Recipient Entity
FOUNDATION MEDICAL PARTNERS
A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100753261
Principal investigator 1 Novo Nordisk AS $232.87 10/31/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096807196
Principal investigator 1 ABBVIE INC. $2,343.60 10/03/2024 Non-covered Recipient Entity
FOUNDATION MEDICAL PARTNERS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1100745624
Principal investigator 1 Novo Nordisk AS $1,017.40 09/20/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096837204
Principal investigator 1 Novo Nordisk AS $2,121.75 08/23/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096800925
Principal investigator 1 Novo Nordisk AS $3,718.98 08/23/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254293
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096719455
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096737096
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096758288
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096762575
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096765225
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096773747
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096778908
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096780232
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096787324
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096791935
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096811148
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096820240
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096825260
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096827544
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096868429
Principal investigator 1 Novo Nordisk AS $160.00 07/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096875964
Principal investigator 1 Novo Nordisk AS $999.81 07/22/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096811696
Principal investigator 1 Novo Nordisk AS $8,361.00 07/22/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254295
Principal investigator 1 ABBVIE INC. $8,603.00 07/05/2024 Non-covered Recipient Entity
FOUNDATION MEDICAL PARTNERS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1100726774
Principal investigator 1 Novo Nordisk AS $5,272.29 07/03/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096866822
Principal investigator 1 Novo Nordisk AS $23.06 06/28/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254415
Principal investigator 1 Novo Nordisk AS $1,333.08 06/21/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096783335
Principal investigator 1 Novo Nordisk AS $13,260.24 06/21/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254299
Principal investigator 1 Novo Nordisk AS $1,612.08 06/21/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254301
Principal investigator 1 Novo Nordisk AS $23.06 06/21/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254413
Principal investigator 1 Novo Nordisk AS $3,997.89 06/11/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254297
Principal investigator 1 Novo Nordisk AS $2,453.98 05/31/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096826434
Principal investigator 1 Novo Nordisk AS $23.06 05/24/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254489
Principal investigator 1 Novo Nordisk AS $223.86 05/22/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254189
Principal investigator 1 Novo Nordisk AS $23.06 05/22/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254191
Principal investigator 1 Novo Nordisk AS $23.06 05/17/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254187
Principal investigator 1 Novo Nordisk AS $942.84 05/09/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9536-4388 No dispute reported 06/30/2026 1096841086
Principal investigator 1 Novo Nordisk AS $2,683.75 04/30/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096772504
Principal investigator 1 Novo Nordisk AS $23.06 04/26/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254185
Principal investigator 1 Novo Nordisk AS $23.06 04/24/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254423
Principal investigator 1 Novo Nordisk AS $23.06 04/19/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254419
Principal investigator 1 Novo Nordisk AS $23.06 04/19/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254421
Recipient ABBVIE INC. $659.60 04/13/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681109
Recipient ABBVIE INC. $42.00 04/13/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681111
Recipient ABBVIE INC. $37.50 04/12/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681101
Recipient ABBVIE INC. $69.00 04/12/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681103
Recipient ABBVIE INC. $50.54 04/12/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681105
Recipient ABBVIE INC. $226.86 04/12/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681107
Recipient ABBVIE INC. $125.05 04/11/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681089
Recipient ABBVIE INC. $25.00 04/11/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681091
Recipient ABBVIE INC. $37.50 04/11/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681093
Recipient ABBVIE INC. $70.25 04/11/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681095
Recipient ABBVIE INC. $226.86 04/11/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681097
Recipient ABBVIE INC. $50.54 04/11/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681099
Recipient ABBVIE INC. $226.86 04/10/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681085
Recipient ABBVIE INC. $25.00 04/10/2024 Covered Recipient Physician A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100681087
Principal investigator 1 Novo Nordisk AS $3,863.18 04/03/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9536-4388 No dispute reported 06/30/2026 1096832371
Principal investigator 1 Novo Nordisk AS $23.06 04/03/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254417
Principal investigator 1 Novo Nordisk AS $4,884.16 03/29/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096719928
Principal investigator 1 Novo Nordisk AS $23.06 03/29/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254567
Principal investigator 1 Novo Nordisk AS $23.06 03/22/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254565
Principal investigator 1 Novo Nordisk AS $5,272.29 02/27/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096843852
Principal investigator 1 Novo Nordisk AS $7.27 02/23/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254405
Principal investigator 1 Novo Nordisk AS $23.06 02/23/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254407
Principal investigator 1 Novo Nordisk AS $23.06 02/21/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254573
Principal investigator 1 Novo Nordisk AS $23.06 02/16/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254571
Principal investigator 1 Eli Lilly and Company $22,576.00 02/14/2024 Non-covered Recipient Entity
FOUNDATION MEDICAL PARTNERS INC
THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) No dispute reported 06/30/2026 1137359867
Principal investigator 1 Novo Nordisk AS $75.00 02/02/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254569
Principal investigator 1 Novo Nordisk AS $942.84 01/30/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9536-4388 No dispute reported 06/30/2026 1096793491
Principal investigator 1 Novo Nordisk AS $4,643.01 01/29/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096781503
Principal investigator 1 Novo Nordisk AS $23.06 01/29/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254487
Principal investigator 1 Novo Nordisk AS $23.06 01/24/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254485
Principal investigator 1 Eli Lilly and Company $1,336.03 01/22/2024 Non-covered Recipient Entity
FOUNDATION MEDICAL PARTNERS INC
THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) No dispute reported 06/30/2026 1137358095
Principal investigator 1 Novo Nordisk AS $23.06 01/19/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254481
Principal investigator 1 Novo Nordisk AS $23.06 01/19/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254483
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096723923
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096748116
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096757808
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096792757
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096809788
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096812396
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096836720
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096841643
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096844922
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096846197
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096868482
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096869199
Principal investigator 1 Novo Nordisk AS $19.95 01/08/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096875231
Principal investigator 1 Novo Nordisk AS $24.56 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096734929
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096745704
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096748192
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096763775
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096774131
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096794099
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096810316
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096811081
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096827885
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096838687
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096840698
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096850001
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096862535
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096868515
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096872903
Principal investigator 1 Novo Nordisk AS $220.00 01/05/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
NN9535-4801 No dispute reported 06/30/2026 1096873091
Principal investigator 1 Novo Nordisk AS $23.06 01/03/2024 Non-covered Recipient Entity
SOUTHERN NEW HAMPSHIRE DIABETES AND ENDOCRINOLOGY
EX9924-4473 No dispute reported 06/30/2026 1155254491